Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 0 | 0 | 0 | 6,346 | 5,824 |
| Cost of Goods | N/A | N/A | N/A | 4,462 | 2,437 |
| Gross Profit | N/A | N/A | N/A | 1,884 | 3,387 |
| Operating Expenses | 11,459 | 10,404 | 11,162 | 15,939 | 15,951 |
| Operating Income | -11,459 | -10,404 | -11,162 | -13,593 | -12,127 |
| Other Income | -625 | -436 | -579 | -536 | -435 |
| Pre-tax Income | -12,084 | -10,840 | -11,741 | -14,129 | -12,562 |
| Income Tax | -999 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -11,085 | -10,840 | -11,741 | -14,129 | -12,562 |
| Net Income Discontinuous | 4,161 | -2,492 | -277 | N/A | N/A |
| Net Income | $-6,924 | $-13,332 | $-12,018 | $-14,129 | $-12,562 |
| EPS Basic Total Ops | -94.71 | -182.38 | -336.56 | -388.70 | -339.34 |
| EPS Basic Continuous Ops | -151.54 | -148.46 | -328.63 | -388.14 | -339.34 |
| EPS Basic Discontinuous Ops | 56.83 | -33.92 | -7.93 | N/A | N/A |
| EPS Diluted Total Ops | -94.71 | -182.38 | -336.56 | -388.70 | -339.34 |
| EPS Diluted Continuous Ops | -151.54 | -148.46 | -328.63 | -388.14 | -339.34 |
| EPS Diluted Discontinuous Ops | 56.83 | -33.92 | -7.93 | N/A | N/A |
| EBITDA(a) | $-10,913 | $-9,831 | $-10,579 | $-12,987 | $-11,530 |